» Authors » Sarah Sterrett

Sarah Sterrett

Explore the profile of Sarah Sterrett including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 21
Citations 489
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Qin K, Honjo K, Sherrill-Mix S, Liu W, Stoltz R, Oman A, et al.
PLoS Med . 2023 Jun; 20(6):e1004157. PMID: 37384638
Background: Patients with chronic lymphocytic leukemia (CLL) have reduced seroconversion rates and lower binding antibody (Ab) and neutralizing antibody (NAb) titers than healthy individuals following Severe Acute Respiratory Syndrome Coronavirus...
2.
Fortmann S, Patton M, Frey B, Tipper J, Reddy S, Vieira C, et al.
Blood Adv . 2023 Mar; 7(15):4200-4214. PMID: 36920790
Several independent lines of evidence suggest that megakaryocytes are dysfunctional in severe COVID-19. Herein, we characterized peripheral circulating megakaryocytes in a large cohort of inpatients with COVID-19 and correlated the...
3.
Qin K, Honjo K, Sherrill-Mix S, Liu W, Stoltz R, Oman A, et al.
medRxiv . 2023 Jan; PMID: 36597532
Chronic lymphocytic leukemia (CLL) patients have lower seroconversion rates and antibody titers following SARS-CoV-2 vaccination, but the reasons for this diminished response are poorly understood. Here, we studied humoral and...
4.
Files J, Sterrett S, Henostroza S, Fucile C, Maroney K, Fram T, et al.
J Virol . 2022 Aug; 96(17):e0119122. PMID: 36000845
Epitopes with evidence of HLA-II-associated adaptation induce poorly immunogenic CD4 T-cell responses in HIV-positive (HIV) individuals. Many such escaped CD4 T-cell epitopes are encoded by HIV-1 vaccines being evaluated in...
5.
Kumar G, Sterrett S, Hall L, Tabengwa E, Honjo K, Larimer M, et al.
Protein Eng Des Sel . 2022 Feb; 35. PMID: 35174857
Quantification of the anti-SARS-CoV-2 antibody response has proven to be a prominent diagnostic tool during the COVID-19 pandemic. Antibody measurements have aided in the determination of humoral protection following infection...
6.
Bansal A, Gehre M, Qin K, Sterrett S, Ali A, Dang Y, et al.
J Clin Invest . 2021 Jul; 131(16). PMID: 34228645
CD8+ T cell responses restricted by MHC-E, a nonclassical MHC molecule, have been associated with protection in an SIV/rhesus macaque model. The biological relevance of HLA-E-restricted CD8+ T cell responses...
7.
Liu W, Russell R, Bibollet-Ruche F, Skelly A, Sherrill-Mix S, Freeman D, et al.
Emerg Infect Dis . 2021 Jul; 27(9):2454-2458. PMID: 34193339
Not all persons recovering from severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection develop SARS-CoV-2-specific antibodies. We show that nonseroconversion is associated with younger age and higher reverse transcription PCR...
8.
Files J, Sarkar S, Fram T, Boppana S, Sterrett S, Qin K, et al.
JCI Insight . 2021 Jun; 6(15). PMID: 34143754
A subset of COVID-19 patients exhibit post-acute sequelae of COVID-19 (PASC), but little is known about the immune signatures associated with these syndromes. We investigated longitudinal peripheral blood samples in...
9.
Honjo K, Russell R, Li R, Liu W, Stoltz R, Tabengwa E, et al.
Cell Rep Med . 2021 Feb; 2(1):100164. PMID: 33521696
Convalescent plasma (CP) is widely used to treat COVID-19, but without formal evidence of efficacy. Here, we report the beneficial effects of CP in a severely ill COVID-19 patient with...
10.
Files J, Boppana S, Perez M, Sarkar S, Lowman K, Qin K, et al.
J Clin Invest . 2020 Oct; 131(1). PMID: 33119547
SARS-CoV-2 causes a wide spectrum of clinical manifestations and significant mortality. Studies investigating underlying immune characteristics are needed to understand disease pathogenesis and inform vaccine design. In this study, we...